Addressing Adherence Issues in a Treatment-experienced, HIV-positive Man

Program Description:

This case study, the first in a series of 3 on HIV, features a 36-year-old gay man whose suboptimal adherence to an HIV treatment regimen results in viral breakthrough and treatment failure. Strategies to improve patient adherence, as well as future treatment options for this patient, will be discussed.

INTENDED AUDIENCE:

Infectious disease/HIV specialists

Activity Objectives:

After taking part in this educational activity, participants should be better able to:

• Apply the most recent data for selection of an antiretroviral regimen for a treatment-experienced patient with HIV


• Utilize tools and interventions to facilitate therapeutic adherence





Credits	Type	Accreditation Statement	Designation Statement
0.50	AMA PRA Category 1 Credit(s)TM	Albert Einstein College of Medicine of Yeshiva University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.	Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CME Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity. This CME activity was planned and produced in accordance with the ACCME Essentials.

Faculty:

W. David Hardy, MD Director, Division of Infectious Diseases Cedars-Sinai Medical Center Associate Professor of Medicine-in-Residence David Geffen School of Medicine at UCLA Los Angeles, CA




Disclosures:

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company.

W. David Hardy, MD, receives grant/research support from Bionor Pharma, Gilead Sciences, Pfizer Inc, ViiV/GlaxoSmithKline, and Tibotec Therapeutics. He is a consultant for Gilead Sciences, Merck, Pfizer Inc, ViiV/GlaxoSmithKline, and Tibotec Therapeutics.

Publishing Staff Disclosures
Ana Albino, Anne Bardsley, Marjorie Hale, and Krista Sierra of Haymarket Medical Education have nothing to disclose with regard to commercial support.

Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Bristol-Myers Squibb, Albert Einstein College of Medicine of Yeshiva University, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Bristol-Myers Squibb, Albert Einstein College of Medicine of Yeshiva University, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

This program is sponsored by Albert Einstein College of Medicine of Yeshiva University.

If you have any questions relating to the accreditation of this activity, please contact Millie Adghiuzor at (718) 920-6674.









Supported by an educational grant from Bristol-Myers Squibb.





Produced by Haymarket Medical Education.








Instructions:

To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

Privacy Policy
To view the myCME privacy policy, please click here.



SYSTEM REQUIREMENTS:

WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.

MACINTOSH^® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20 MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands of Colors”; Macromedia Flash Player 6 or higher.